Trial
NCT02470585
Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
AbbVie
Collaborators
Australia New Zealand Gynaecological Oncology Group
Condition
Ovarian Cancer
Intervention
Veliparib
Why stopped
Business decision not related to patient safety
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-26